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Atrial natriuretic factor in the acute nephrltic and nephrotic syn-
dromes. Because the role of systemic hormones in the pathophysiology
of edema in acute renal disease remains incompletely understood, we
compared the levels of atrial natriuretic factor (ANF) and plasma renin
activity (PRA) in patients with acute glomerulonephritis (AGN), ne-
phrotic syndrome (NS), and normal individuals during salt deprivation
and salt loading. Sixteen patients with AGN (10 males) and nine
patients with NS and hypoalbuminemia (7 males) were studied on
admission, and after recovery (12 AGN patients) or remission (4 NS
patients). Eighteen normal controls were each studied after five days on
a low (20 mEq Na/day), regular (120 mEq Na/day) and high (300 mEq
Na/day) dietary salt intake. Patients with AGN and NS had comparable
edema (AGN 2.8 0.53 kg; NS 3.36 0.47 kg; SE) and urinary Na
excretion (mean SEM: AGN 0.97 0.11 mEq/hr; NS 1.06 0.16
mEq/hr), but AGN patients had five times higher ANF (AGN 27.2
4.06 fmol/ml; NS 5.51 1.02 fmol/ml; P < 0.001) and six times lower
PRA ng/liter• sec levels (AGN 0.187 0.047; NS 1.144 0.222; P <
0.001) than NS patients. The degree of edema was correlated with ANF
levels in AGN patients (P < 0.001) but not in NS patients. There was a
strong exponential negative correlation (r = —0.773, P < 0.0001)
between ANF and PRA, in which AGN patients and Na-restricted
controls were located in the opposite ends of the volume sensing-
response, and NS patients in the middle, alongside controls with regular
Na intake. Our studies suggest that intrarenal mechanisms are respon-
sible for Na retention in AGN as well as in NS, but AGN patients have
a compensatory hormonal response related to the degree of fluid
retention, while volume-sensing receptors in hypoalbuminemic NS
patients are neither actively stimulated nor suppressed, probably due to
increased transudation of fluid out of the capillaries.
Evaluation of volume sensing hormones is a useful approach
to understand the pathophysiology of renal conditions charac-
terized by sodium retention and edema. When edema results
from an intrarenal defect causing impaired sodium excretion, as
in acute glomerulonephritis, the hormonal systems show a
compensatory response triggered by, and directed to correct,
an expanded plasma volume. In contrast, when the hormonal
changes reflect a contracted intravascular compartment, it is
assumed that the kidney is responding appropriately to a
homeostatic need with sodium retention. The latter situation
was thought to be characteristic of the nephrotic syndrome, in
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which hypoalbuminemia could be the driving force of the
transudation of fluid out of the capillaries. However, this
attractive explanation was not substantiated in several studies
that showed significant variability and normal mean levels of
plasma renin activity [1—5] and atrial natriuretic factor [6, 7] in
nephrotic patients.
Further insight into these issues could be gained, in our
opinion, by comparing patients with acute glomerulonephritis
and patients with nephrotic syndrome, with control individuals
under sodium restriction as well as sodium loading. The two
patient groups should offer a pathophysiological contrast, and
the normals, on low and high salt diets, should encompass the
limits of a physiologic hormonal response. This paper reports
such an investigation with respect to atrial natriuretic factor and
plasma renin activity.
Methods
Patients
Studies were done in 16 patients with acute glomerulonephri-
tis (AGN), and 9 patients with nephrotic syndrome (NS).
Patients with AGN, 10 males and 6 females, ranged in age
from 2 to 19 years. Thirteen of them had poststreptococcal
etiology. These patients were studied upon admission and 12 of
them were studied again 5 to 10 days later, after diuresis had
occurred. Eight patients had repeated evaluation, including
ANF determinations, 4 four 12 weeks after discharge. The
initial studies were done at the time of admission before any
medication was given, or in three cases, after more than four
hours had elapsed from a dose of furosemide (20 mg intrave-
nously) given before admission. During hospitalization, antihy-
pertensive treatment and loop diuretics were given in the first
few days as dictated by the clinical conditions, but all medica-
tions had been discontinued at least three days before the time
when the studies in the convalescence period were done. Low
salt diet (20 mEq Na per day) was followed by these patients
throughout their hospitalization, including at the time of the
postacute studies.
Patients with NS (7 males, 2 females) ranged in age from 8 to
18 years. They were diagnosed as having membranoprolifera-
tive glomerulonephritis (2 patients), membranous glomerulone-
phritis (2 patients, one of them due to lupus erythematosus),
minimal change disease (1 patient), poststreptococcal glomeru-
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lonephritis (1 patient), and steroid-responsive nephrotic syn-
drome, presumed to be minimal change disease (no biopsy was
done, in 3 patients). These patients had the full spectrum of the
nephrotic syndrome, including proteinuria ranging from 4.1 to
7.2 glday, and hypoalbuminemia ranging from 1.8 to 2.4 g/dl.
They were studied within 48 hours of admission, before a
definite diagnosis was established. None was receiving steroids
at that time. They were prescribed a sodium restricted diet,
similar to that of the patients with AGN, and had not received
diuretic medication for at least eight hours before studies were
done. At a later time, patients with NS were evaluated to decide
which patients had remission and did not require continued
medication; this was the case in three patients with minimal
change disease and one patient with poststreptococcal etiology.
These four patients had repeated studies after remission of NS
three to eight weeks after the initial studies.
All patients had a complete physical examination, blood
pressure determinations by at least two observers, and their
weight was determined by the same person (DC) at the same
time of the day and with the same clinical equipment to a
discrimination of 0.1 kg. Supervised urinary collections of one
to four hours were obtained in the patients at the time of
admission because diuretic therapy could not be postponed for
longer time, and 24-hour urine collections were done after
recovery for determination of sodium and creatinine excretion.
Blood for atrial natriuretic factor (ANF) and plasma renin
activity (PRA) determination was drawn in the sitting or semi-
recumbent position after 30 minutes of rest in every occasion.
Controls
Eighteen normal individuals (10 males), ranging in age from 4
to 22 years (median 16 years) were used as control group. They
were apparently healthy and had a normal physical examina-
tion. Their serum hemoglobin, albumin, creatinine and urine
analysis were also normal. Each of them was studied during
three isocaloric sodium intakes: low (20 mEq Na per day),
normal (120 to 150 mEq Na per day) and high (300 mEq Na per
day). The high sodium diet required supplementation with NaCI
in prepared capsules. Blood pressure and weight were deter-
mined daily in the morning. Compliance with the prescribed
diet was tested by determination of 24-hour urinary sodium
excretion. Studies were done after five days on the correspond-
ing diet when blood was drawn at 8 a.m. after 30 minutes of rest
in the sitting position for determination of ANF and PRA.
Laboratory determinations
Plasma levels of immunoreactive ANF (i-ANF) were deter-
mined in 6 ml blood as described previously [81. Samples were
obtained in ice-chilled tubes containing 1 mg ethylenediamine-
tetra acetate, 10 p1 methanesulphonyl fluoride (10 to 3 molI
liter), and 10 p1 pepstatin A (500 molI1iter), per ml of blood to
prevent degradation of ANF. Samples were immediately spun
for 20 minutes at 4°C and stored at —70°C until assayed.
Specific radioimmunoassay was used to determine i-ANF [9]
after extraction with Sep-Pak cartridges (Waters Associates,
Milford, Massachusetts, USA) as described before [10]. Sensi-
tivity of the assay was 0.29 fmollml, and i-ANF levels were not
corrected for recovery, which was 80 to 94% [8].
Plasma renin activity was determined as described previously
[11] with commercially available radioimmunokits (SB-REN-l,
Compagnie Oris Industrie S.A., Gif sur Ivette, France). Uri-
nary and serum electrolytes were determined by flamephotom-
etry and serum albumin and blood chemistries by autoanalyzer
methodology.
Cardiovascular status
A complete physical examination, (including evaluation of
breathing, neck veins, lungs and heart) routine laboratory test,
creatinine clearances and chest X-rays were done in all pa-
tients. Mean arterial pressure (MAP) was calculated as:
MAP = (systolic + 2 diastolic)
3
Edema was calculated by subtracting the edema free weight
found after recovery from the admission weight. Weight
changes in the control group were noted as the difference in
weight between the first and last day of the corresponding
sodium diet.
Non-invasive assessment of cardiac output and stroke vol-
ume by echocardiography was done in five patients with AGN
(patients AGN 2, 3, 6, 8, 10 in Table 1) and one patient with NS
(NS 9 in Table 2).
Statistical methods
Results are expressed as mean SEM or SD, as indicated.
Statistical differences were calculated by independent or paired
samples t-test, as well as by non-parametric methods (Wilcox-
on's rank sum and signed rank test). Correlations were calcu-
lated by parametric (Pearson's correlation) and non-parametric
(Spearman's correlation) methods. P values were similar with
both statistical approaches and the values of parametric meth-
ods are used in the text. Results were considered significant if
two-tailed P values were <0.05. Statistical analysis was done
with the help of a commercially available, statistical computer
package (Statgraphics®, STSC Inc., Rockville, Maryland,
USA).
Results
Table 1 shows the individual patients' data. Patients with
AGN had ANF values ranging from 4.9 fmollml to 52.3 fmollml.
In contrast, patients with the NS who had comparable degree of
edema and similar urinary sodium excretion had mean values of
ANF and PRA that were five times lower and six times higher,
respectively, than the values found in patients with the acute
nephritic syndrome (Table 1). The creatinine clearance (mI/mm
corrected for 1.73 m2 surface area; mean SEM) of patients
with AGN was 55 4.63, and in patients with the NS it was
77.9 11.55 (P < 0.01, Table 1). No significant correlation was
found between ANF levels and the creatinine clearance; how-
ever, AGN patients 2, 6 and 10 had values of 30 to 40 mLtmin
(Table 1).
Patients with AGN showed evidence of intravascular over-
load that, in general, correlated with the degree of edema and
hypertension (Table 1). Patients AGN2, AGN7 and AGN1O had
tachypnea, orthopnea, distended neck veins and a tender liver
3 to 4 cm below the costa! margin. The chest X-ray taken on
admission showed cardiomegaly in patient AGN6 and parahilar
pulmonary vascular engorgment which disappeared after diure-
sis (as determined by comparison with another chest X-ray
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Table 1. Patients' data
Blood Urinary
Patient pressure Edema Cr sodium PRA ANF
(Age, sex) Diagnosis mm Hg kg mi/mm pEq/min ng/liter. sec fmol/ml
AGN1 (13,M) PSGN 165/110 1.5 60.5 20.8 0.089 23.9
AGN2 (14,M) PSGN 141/92 7.0 40.2 28.8 — 49.4
AGN3 (8,F) PSGN 120/85 0.9 50.0 11.3 0.369 21.3
AGN4 (13,M) PSON 151/112 3.3 38.9 27.9 0.247 32.7
AGN5 (19,F) PSGN 160/103 2.4 80.1 17.5 0.294 18.0
AGN6 (12,F) — 136/90 5.4 36.2 21.9 0,067 52.3
AGN7 (13,M) PSGN 128/91 4.1 61.2 7.9 0.064 40.4
AGN8 (12,M) — 158/100 4.1 63.1 14.8 — 27.6
AGN9 (3,M) PSGN 140/100 1.1 43.2 8.7 — 10.9
AGN1O (14,F) PSGN 150/1 10 5.0 30.1 4.7 0.006 54.6
AGN11 (13,M) — 140/100 1.1 28.1 17.5 0.178 24.8
AGN12 (2,F) PSGN 130/80 — 72.1 17.6 0.075 39.5
AGN13 (6,M) PSGN 120/85 — 55.5 10.8 — 10.2
AGNI4 (5,M) PSGN 137/83 0.8 80.1 9.3 0.572 4.86
AGN15 (5,M) PSGN 160/110 1.3 52.1 12.6 0.178 8.07
AGN16(4,F) PSGN 143/88 1.7 88.1 26.5 0.108 15.8
Mean 2.84 55.0 16.16 0.187 27.2
SEM 0.532 4.63 1.864 0.047 4.06
NS1 (l8,M) MPGN 160/1 12 3.0 40.2 26.5 0.506 12.5
NS2 (14,M) MON 130/100 3.5 80.1 6.0 1.342 5.4
NS3 (12,M) MPGN 150/103 1.8 63.1 7.1 0.222 7.1
NS4 (8,F) MCD 90/79 3.1 108.9 15.6 0.778 6.8
NS5 (12,M) MCD 130/80 4.8 131.1 18.5 — 4.1
NS6 (15,M) PSGN 135/90 3.2 38.1 22.3 2.060 3.8
NS7 (12,M) MON (SLE) 118/75 2.5 68.6 22.5 1.811 2.1
NS8 (9,F) MCD 110/70 2.0 103.0 27.6 1.364 4.0
NS9 (1l,M) MCD 90/65 6.3 98.3 13.3 1.072 3.8
Mean 3.36 77,9C 17.71 1144b 55b
SEM 0.47 11.55 2.618 0.222 1.02
Abbreviations are: AGN, acute glomerulonephritis (acute nephritic syndrome); NS, nephrotic syndrome with serum albumin <2.5 g/dI; PSON,
post-streptococcal glomerulonephritis; MPGN, membranoproliferative glomerulonephritis; MGN, membranous nephropathy; MCD, minimal
change disease; SLE, systemic lupus crythematosus; PRA, plasma renin activity; ANF, atrial natriuretic factor; Cr, creatinine clearance
corrected for 1.73 m2.
a Biopsy not done. Edema calculated by the difference in admission weight and dry weigh after recovery (AGN) or remission (NS).
"P < 0.001 vs. patients with AGN
P < 0.001 vs. patients with AGN
Table 2. Atnal natriuretic factor and renin activity in acute glomerulonephritis, nephrotic syndrome and controls
U P
protein albumin
UNaV
mEq/hr
Weight gain
kg
g/day g/dl PRA
ng/liter. sec
ANF
fmoi/mIrange
Controls (N = 18)
20 mEq Na/day 0.93 0.08 —0.050 0.087 — — 2.430 0.190 3.450 0.370
120—150 mEq Na/day 5.29 0.18 0.001 0.087 Neg 3.8—5.1 1.420 0.143 6.220 0.510
300 mEq Na/day 12.04 0.44 0.892 0.090 — — 0.580 0.060 11.560 1.142
AGN (N = 16) 0.97 0.11 2.840 0.532 0.4—1.1 3.1—4.8 0.187 O.047a 27.20 4.06a
NS (N = 9) 1.06 0.16 3.36 0.47 4.1—7.2 1.8—2.4 1.144 0.222" 5,51 l.02c
Data in controls were obtained after 5 to 6 days in the corresponding Na diet. Urinary Na excretion (UNaV) in controls was measured in 24-hour
urine collections. Values of urinary Na excretion in AGN and NS patients were calculated from 4-hour urine samples obtained on admission.
Abbreviations are: AGN, acute glomerulonephritis; NS, nephrotic syndrome; PRA, plasma renin activity; ANF, atrial natriuretic factor. Values
are mean SEM, except for urinary protein excretion (U protein) and plasma albumin (P albumin) where the range is given.
a P < 0.001 vs. controls in any Na intake
"P < 0.01 vs. controls in high and low Na diets
P < 0.05 vs. controls in low Na diet and P < 0.01 vs. controls in high Na diet
taken in convalescence) in patients 2, 6, 7, 10 and 15. Patients raphy in five patients with AGN and one patient with NS. Three
1, 3, 5 and 14 did not have chest films repeated after recovery. AGN patients showed increased cardiac output (N = 2.7 to 3.9
Cardiac output was determined on admission by echocardiog- liter/min/m2 surface area) and stroke index (N = 35 to 45
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0
Admission + 5-10 days
Fig. 1. Individual values of plasma atrial natriuretic factor (ANF) in
patients with acute glomerulonephritis. Data correspond to values on
admission and at the time when clinical edema had completely, or
almost completely, resolved 5 to 10 days later. Only 12 patients are
shown because the postacute data was not available in 4 of 16 patients.
mi/min/m2 surface area). Patient AGN2 (Table 1) had a cardiac
output and stroke volume of 4.22 liter/minIm2 and 49.7 mllmini
m2, respectively; patient AGN8 had 4.53 liter/min/m2 of cardiac
output and 53.9 mi/minIm2 stroke volume, and patient AGN1O
had 7.77 liter/minIm2 and 75.4 mi/min/m2 of cardiac output and
stroke index, respectively. Cardiac output was normal in pa-
tients AGN3 (3.10 liter/min/m2) and in patient NS9 (3.5 liter!
minim2). As shown in Table 1, this last patient had 6.3 kg of
edema, corresponding to 17.7% increase in body weight.
Table 2 shows the data of control subjects in low, normal and
high salt intake, in comparison with the mean data obtained in
the patients. In controls in a low (20 mEq Na/day), regular (120
to 150 mEq Na/day) and high (300 mEq Na/day) salt intake, the
urinary Na excretion in 24-hour urine collections were 22.3
1.4 mEq Na/day, 126.9 mEq Na/day and 289.0 10.35 mEq
Na/day, (mean SEM) respectively. These data are shown as
hourly Na excretion rates in Table 2 to compare it with the
patients' data, which was obtained in one to four hour urine
samples obtained on admission. Patients with AGN had ANF
levels that were higher than the values observed in normal
subjects on any sodium intake, including 300 mEq per day;
correspondingly, PRA levels were more suppressed in AGN
patients than in normals on a high salt diet. In contrast, the
patients with NS had mean ANF and PRA levels that were
comparable to those of normal individuals on a regular sodium
diet (120 to 150 mEq Na per day). ANF levels were less
stimulated in edematous nephrotic patients than in normal
subjects on a high salt intake, and less suppressed than in
sodium-retaining normal subjects (Table 2).
The acute nephritic syndrome of the patients with AGN had
subsided, or was much improved, 5 to 10 days after admission;
ANF levels decreased from 27.5 SEM 4.04 fmol/ml on
admission, to 13.6 3.19 fmol/ml at 5 to 10 days later. The
individual patients are shown in Figure 1. ANF levels were
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Fig. 2. Relationship between plasma atrial natriuretic factor (ANF)
and weight gain (calculated as the difference between admission weight
and dry weight) expressed as percent change of dry weight. The
correlation in patients with acute glomerulonephritis () is highly
significant (r = 0.825, P < 0.001, Y = 9.37 + 2.55X) but is not present
in patients with nephrotic syndrome (•). Control subjects on a diet of
300 mEq Na per day are shown as the open square (mean 5EM).
determined in eight patients 4 to 12 weeks after discharge while
on a free Na diet (not shown). At that time, ANF levels were
5.50 0.80 fmol/ml, not significantly different from controls
(6.22 0.5 10 fmol/ml, Table 2).
Re-evaluation of ANF levels in remission and receiving no
medication was only possible in four patients with the NS
(patients NS4, NS5, NS6 and NS9). The changes observed after
improvement in the nephrotic syndrome were inconsistent:
patient NS6 had an increase in ANF levels in remission to 4.6
fmol/ml from the admission level of 3.8 fmol/ml. In contrast,
patients NS4, NS5, and NS9 had a fall in their ANF levels
(fmoi/ml) to values of 3.6 (from 6.8 fmollml), 3.8 (from 4.1
fmollml) and 3.0 (from 3.8 fmol/ml), respectively.
There was a significant correlation between fluid retention
and ANF stimulation in AGN. This was found whether fluid
retention was expressed as absolute weight gain (r =0.888, P <
0.001) or as percent increase above the dry weight (r = 0.825, P
<0.001). Figure 2 shows the later relationship in contrast with
the lack of correlation between edema and ANF levels in the
nephrotic syndrome.
Blood pressure was not correlated with ANF levels in AGN,
but a significant correlation existed between mean arterial
pressure (MAP) and ANF levels in NS patients (r =0.681, P <
0.05).
Data obtained in all patients showed an exponential correla-
tion between PRA and ANF levels (r =
—0.773, P < 0.0001).
Control subjects with various salt intakes fit well in the data of
the AGN and NS patients (Fig. 3).
Discussion
The pathophysiology of edema in acute inflammatory renal
disease is a subject of continued interest. Traditional explana-
tions for sodium retention postulate that in the acute nephritic
syndrome due to AGN, impaired sodium excretion is the result
of an intrarenal disorder, while in the nephrotic syndrome the
low urinary sodium is a compensatory response to a decreased
"effective" intra-vascular volume.
In the case of AGN, several investigators [12, 13], including
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Fig. 3. Exponential relationship [Y = exp(3.092 — 0.968X); r = —0.773,
P < 0.0001J between atrial natriuretic factor (ANF) and plasma renin
activity (PRA) in acute glomerulonephritis (open triangles, , acute
phase: closed triangles, V, convalescence), nephrotic syndrome (open
circles, 0, crisis; closed circles, •, remission)and controls (bars, mean
SD) with intake of 20, 120 and 300 mEq Na per day.
ourselves [11], have shown that PRA is appropriately sup-
pressed in relation to the degree of fluid retention. To our
knowledge, ANF levels previously have not been measured in
patients with AGN, and the findings that we report in this paper
are indicative of compensatory stimulation of ANF in response
to sodium and fluid retention resulting from a primary intrarenal
mechanism. Nevertheless, alterations in metabolism or clear-
ance of ANF in AGN may play a contributing role in patients
with severely impaired renal function. The increased cardiovas-
cular overload of patients with AGN was evident in the clinical
findings at their admission. Cardiac output was increased in
three AGN patients and normal in another two. The existence
of high-output heart failure in many patients with AGN is a
well-recognized finding [reviewed in ref 14], unfortunately, a
critical assessment of atrial size was not made and correlations
with this parameter are not possible. However, the fall of ANF
values after diuresis was begun and edema had resolved (Fig.
1), and the further decrease of ANF after 4 to 12 weeks of
convalescence to levels similar to control subjects in convales-
cence, are congruent with a compensatory hormonal stimula-
tion. The striking correlation between the degree of fluid
retention (estimated by the difference in weight between admis-
sion and recovery) and the levels of ANF, shown in Figure 2, is
also consistent with this interpretation. It is also possible that
the half-life of ANF was prolonged in the patients with mark-
edly depressed GFR. This factor, per se, appears to be less
important than volume expansion since ANF levels are not
correlated with creatinine clearance. However, it could cer-
tainly have contributed to the high ANF values found in
patients AGN2, AGN6 and AGN1O, who had creatinine clear-
ances (which in renal failure overestimate GFR) of 30 to 40
mI/mm/i .73 m2 (Table 1). Renal function was more impaired in
patients with AGN than in patient with NS (Table 1), but this
cannot explain the differences between NS and AGN since
patients NS 1 and NS6 had creatinine clearances which were
depressed to a similar degree as patients AGN2, AGN6 and
AGNIO, yet had much lower ANF levels.
The situation in patients with NS is more complex. Plasma
volume has been found to be decreased in only 30% of the
of the vascular system. Therefore, hypoalbuminemia should
exert a dampering effect on the stimulation of volume-sensing
mechanisms in a fluid retaining patient. In these circumstances,
a better insight is gained if the hormonal responses are com-
pared in groups of patients with comparable edema and urinary
sodium excretion, who present (nephrotics) or not (acute gb-
merubonephritis) with hypoalbuminemia. In addition, appropri-
ateness of a response may be best evaluated in comparison with
controls with physiologically stimulated (low sodium diet) or
maximally suppressed (high sodium diet) urinary sodium excre-
tion (Table 2).
The levels of ANF in normal subjects on 120 to 150 mEq Na
per day (6.22 0.51 fmollml, SE, Table 2) are comparable to
findings from our laboratories reported previously in the general
population (5.77 0.37 fmol/ml, SEM, N = 45) [8]. Changes in
sodium intake induced variation in PRA and ANF levels in our
control subjects which are comparable to those reported by
others [11, 16, 17]. It is interesting that patients with NS
resemble, with respect to their ANF and PRA levels, normal
individuals on a regular sodium intake who are neither intensely
retaining or eliminating sodium (Table 2). The results are not
different from the findings in several reports which show that
nephrotic patients as a group have mean levels of PRA [1—5] and
ANF [6, 7] within the limits found in normals in unrestricted
sodium intake. In fact, some of the confusion pertaining to
levels of volume sensitive hormones in NS may be due to
defining "low" or "high" levels in relation to normals, whose
sodium intake may vary widely, and to the lack of control
determinations in normals during hormonal suppression and
stimulation.
There is no correlation between edema and ANF levels in NS
patients (Fig. 2). Only the three values of ANF in nephrotics
(NS1, NS3, NS4), are within 2 SD of the mean value of ANF in
normals stimulated with a high salt diet (11.56 4.84 fmollml,
SD). Therefore, it is evident that ANF and PRA responses do
not promote maximal sodium excretion in nephrotic patients,
though fluid retention ranged from 1.8 kg to 6.3 kg (Table 1),
representing 6% and 22% gain in body weight, respectively. By
similar reasoning, ANF and PRA responses in NS also do not
actively retain sodium, since the levels of these hormones do
not meet the values found in normals on a low sodium diet
(Table 2).
Evaluation of PRA and ANF in a spectrum of patients and
controls permitted a wide range of physiologic and pathophys-
iologic levels of these hormonal systems to be covered which
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A patients with NS, while the rest have normal or increased
values [3]. Determinations of plasma volume depend on the
distribution of the marker and overestimation is expected if
there is leaking out of the vascular tree. Even if the error
A introduced in this fashion is small, as suggested by Geers et al
[15], measurements of plasma volume are suspect in hypoalbu-
A minemic patients. Because of these difficulties, attention has
A been turned to the volume sensitive hormones that may reflect
A
,
the "effective" or perceived state of intravascular filling. Yet,
1
________________
the role of volume sensitive hormones in the sodium retention
A • 3j o • J remains a matter of controversy. Patients with full blown
0 0 5 1 1 5 2 5 nephrotic syndrome have low urinary sodium excretion and
edema, as do patients with AGN, but they also have hypoalbu-
PRA,ng// S minemia. Alteration of Starling's equilibrium forces resulting
from decreased oncotic pressure facilitates fluid movement out
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have opposing actions on sodium and water balance; an expo-
nential relationship with a strong negative correlation was
found (Fig. 3). From this relationship it may be appreciated that
in volume-contracted sodium retaining states, changes in the
stimulated PRA levels are more sensitive than changes in the
correspondingly suppressed ANF levels; the opposite is true in
conditions characterized by volume expansion. As shown in
Figure 3, patients with AGN and normal individuals on a
sodium restricted diet occupy the opposite ends of the hor-
monal volume-sensing reponse. Patients with NS are located in
the middle ground alongside controls on a regular sodium diet.
Our findings suggest that volume sensitive hormones are not
responsible for the fluid and sodium retention in patients with
NS. Work from other laboratories has also failed to incriminate
extrarenal hormonal influences in the sodium retention of these
patients: Brown et al [18] and Koomans et al [19] have reported
that plasma expansion to normal levels failed to reverse the
positive sodium balance, and Peterson et al [20] found that
increments of plasma ANF induced with water immersion were
not associated with a normal natriuretic response. Captopril-
induced suppression of the renin-angiotensin system failed to
produce a natriuresis [18]. Finally, experimental studies inject-
ing puromycin aminonucleoside in one renal artery have shown
that the affected nephrotic kidney, but not the contralateral
control, retains sodium despite the absence of hypoalbuminuria
and, therefore, with a presumably non-contracted intravascular
volume [21, 22].
In view of the accumulated clinical and experimental evi-
dence and our own data reported here, it appears likely that
intrarenal mechanisms are responsible for fluid retention in both
NS and AGN. The existence or absence of hypoalbuminemia
may be one of the factors responsible for a different level of
stimulation of the systems involved in volume homeostasis in
the patients with AGN and NS. These systems are clearly
sensing a more expanded intravascular status in patients with
AGN at all levels of fluid retention than in patients with NS, and
are responding accordingly (Fig. 2).
It is, of course, conceivable that the "suboptimal" ANF
responses to fluid retention observed in the patients with NS,
shown in Figure 2, could be the result of defects in the sensing
volume receptors or in the production of ANF. However, these
possibilities appear unlikely because ANF stimulation after
head-out water immersion and volume expansion is normal or
supranormal in these patients [7, 20].
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